Literature DB >> 22528475

Cytokine levels in CSF and neuropsychological performance in HIV patients.

Thorsten Nolting1, Antje Lindecke, Hans-Peter Hartung, Eleni Koutsilieri, Matthias Maschke, Ingo-W Husstedt, Sieghart Sopper, Olaf Stüve, Gabriele Arendt.   

Abstract

HIV-associated dementia and its precursors are frequently observed complications of HIV infection, even in the presence of combination antiretroviral treatment (cART). The development, surveillance and treatment of this condition are still not completely understood. Cytokines, as immunological transmitters, may be one key to gaining a deeper understanding of the disease. A total of 33 HIV-positive male patients were evaluated by neuropsychological testing, lumbar and venous puncture, neuroimaging and neurological examination. The cytokine content in the CSF (cerebrospinal fluid) was examined by a solid-phase protein array. The Digit-Symbol Test, contraction time analysis, Rey-Osterrieth Figure and Grooved-Pegboard Test showed inferior results in the presence of an inflammatory CSF environment, whereas neuroprotective or anti-inflammatory conditions were correlated to better results in contraction time analysis. Higher CSF levels of cytokines were independently correlated with the duration of HIV infection. The study showed a correlation of cytokine levels in the CSF of HIV patients with test results of their neuropsychological functioning. The effect was pronounced with regard to the more complex executive tasks. Determining CSF cytokine levels may be a useful supplement to the assessment of HIV patients and contribute helpful information to predict neurocognitive performance. Therapeutic strategies to ameliorate a negative impact of an altered cytokine milieu may aid in slowing the evolution of neurocognitive dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528475     DOI: 10.1007/s13365-012-0091-4

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  36 in total

Review 1.  Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap.

Authors:  Justin C McArthur; Joseph Steiner; Ned Sacktor; Avi Nath
Journal:  Ann Neurol       Date:  2010-06       Impact factor: 10.422

Review 2.  A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Authors:  Stephanie D Kraft-Terry; Shilpa J Buch; Howard S Fox; Howard E Gendelman
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

3.  Anterior cingulate activation and error processing during interferon-alpha treatment.

Authors:  Lucile Capuron; Giuseppe Pagnoni; Marina Demetrashvili; Bobbi J Woolwine; Charles B Nemeroff; Gregory S Berns; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2005-08-01       Impact factor: 13.382

4.  Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis.

Authors:  B Wildemann; K Ehrhart; B Storch-Hagenlocher; U Meyding-Lamadé; S Steinvorth; W Hacke; J Haas
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

Review 5.  Current understanding of HIV-associated neurocognitive disorders pathogenesis.

Authors:  Patrick Gannon; Muhammad Z Khan; Dennis L Kolson
Journal:  Curr Opin Neurol       Date:  2011-06       Impact factor: 5.710

6.  CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

Authors:  D B Clifford; A M Fagan; D M Holtzman; J C Morris; M Teshome; A R Shah; J S K Kauwe
Journal:  Neurology       Date:  2009-11-11       Impact factor: 9.910

7.  Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.

Authors:  Gabriele Arendt; Thorsten Nolting; Christian Frisch; Ingo-Wilhelm Husstedt; Nora Gregor; Eleni Koutsilieri; Mattias Maschke; Alexander Angerer; Mark Obermann; Eva Neuen-Jacob; Ortwin Adams; Sabine Loeffert; Peter Riederer; Volker ter Meulen; Sieghart Sopper
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

8.  Neurocognitive functioning in acute or early HIV infection.

Authors:  David J Moore; Scott L Letendre; Sheldon Morris; Anya Umlauf; Reena Deutsch; Davey M Smith; Susan Little; Alexandra Rooney; Donald R Franklin; Ben Gouaux; Shannon Leblanc; Debra Rosario; Christine Fennema-Notestine; Robert K Heaton; Ronald J Ellis; J Hampton Atkinson; Igor Grant
Journal:  J Neurovirol       Date:  2010-12-15       Impact factor: 2.643

9.  Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment.

Authors:  Ixane Velázquez; Marinés Plaud; Valerie Wojna; Richard Skolasky; Juliana Pérez Laspiur; Loyda M Meléndez
Journal:  J Neuroimmunol       Date:  2008-12-19       Impact factor: 3.478

Review 10.  Immune responses to RNA-virus infections of the CNS.

Authors:  Diane E Griffin
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

View more
  8 in total

Review 1.  Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.

Authors:  Sheila M Keating; Evan S Jacobs; Philip J Norris
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

2.  HIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse.

Authors:  Nazira El-Hage; Myosotys Rodriguez; Seth M Dever; Ruturaj R Masvekar; David A Gewirtz; John J Shacka
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

Review 3.  Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.

Authors:  Alexander J Gill; Dennis L Kolson
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

4.  Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.

Authors:  Dionna W Williams; Tina M Calderon; Lillie Lopez; Loreto Carvallo-Torres; Peter J Gaskill; Eliseo A Eugenin; Susan Morgello; Joan W Berman
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

Review 5.  Heme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders.

Authors:  Surendra S Ambegaokar; Dennis L Kolson
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

6.  Release of Soluble Insulin Receptor From Neurons by Cerebrospinal Fluid From Patients With Neurocognitive Dysfunction and HIV Infection.

Authors:  Yamil Gerena; Raissa Menéndez-Delmestre; Andrea Delgado-Nieves; Joyce Vélez; Jarold Méndez-Álvarez; Javier E Sierra-Pagan; Richard L Skolasky; Lisa Henderson; Avindra Nath; Valerie Wojna
Journal:  Front Neurol       Date:  2019-03-26       Impact factor: 4.003

Review 7.  Microglial Cells: The Main HIV-1 Reservoir in the Brain.

Authors:  Clementine Wallet; Marco De Rovere; Jeanne Van Assche; Fadoua Daouad; Stéphane De Wit; Virginie Gautier; Patrick W G Mallon; Alessandro Marcello; Carine Van Lint; Olivier Rohr; Christian Schwartz
Journal:  Front Cell Infect Microbiol       Date:  2019-10-24       Impact factor: 5.293

8.  Tristetraprolin expression and microRNA-mediated regulation during simian immunodeficiency virus infection of the central nervous system.

Authors:  Jonathan Liu; Jeanne M Sisk; Lucio Gama; Janice E Clements; Kenneth W Witwer
Journal:  Mol Brain       Date:  2013-09-02       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.